SCOPE Summit 2025: Addressing Challenges in Clinical Data Management and Analytics
February 12th 2025In an interview with Applied Clinical Trials Associate Editor Don Tracy, Shakthi Kumar, chief strategy & business officer, Edetek, discusses how Edetek's R&D cloud system addresses challenges in clinical data management.
SCOPE Summit 2025: Enhancing the Patient Experience Through Site Centricity
February 12th 2025In an interview with ACT senior editor Andy Studna at SCOPE Summit, Ashley Davidson, vice president, product lead - sponsor tech strategy, Advarra, highlights the need for more site-centric approaches in study startup.
SCOPE Summit 2025: Richard Young on CluePoints' Approach to Risk Detection in Clinical Trials
February 7th 2025In an interview with Applied Clinical Trials Associate Editor Don Tracy, Richard Young, chief strategy officer, CluePoints, discusses goals of the SCOPE Summit and CluePoints' evolving approach to risk detection.
SCOPE Summit 2025: Veeva’s Drew Garty Discusses Pragmatic Clinical Trials
February 5th 2025In an interview with ACT senior editor Andy Studna at SCOPE Summit, Garty, chief technology officer, clinical data, provided his key takeaways from a panel he participated in on the growing interest around pragmatic studies.
SCOPE Summit 2025: Advarra’s Ashley Davidson Highlights Current Challenges with Study Startup
February 4th 2025In an interview with ACT senior editor Andy Studna at SCOPE Summit, Davidson, vice president, product lead - sponsor tech strategy, Advarra, discussed ongoing challenges in study startup processes, including contract and budget issues, and feasibility concerns, which have persisted for over a decade.
SCOPE Summit 2025: Jonathan Norman of YPrime Discusses the Need for Localization in Clinical Trials
February 4th 2025In an interview with ACT senior editor Andy Studna at SCOPE Summit, Norman, director, localization services, YPrime discussed how localization is becoming increasingly important as clinical trials become more global.
How the Multiple Myeloma Research Foundation is Partnering With Biopharmas
February 3rd 2025In this video interview, Michael Andreini, president and CEO of the Multiple Myeloma Research Foundation, highlights how the MMRF accelerates trial timelines for biopharmas by integrating an adaptive platform model.
Answering Critical Research Questions in Multiple Myeloma
January 30th 2025In this video interview, Michael Andreini, president and CEO of the Multiple Myeloma Research Foundation, talks unmet need in the multiple myeloma space and how the Horizon trial is addressing complexity in treatment regimens.
Addressing Clinical Research Challenges in the Myeloma Space
January 28th 2025In this video interview, Michael Andreini, president and CEO of the Multiple Myeloma Research Foundation (MMRF), discusses the greatest challenges with clinical trials in multiple myeloma and how MMRF is aiming to address them.